[Cell Stem Cell] Ethical and Policy Issues in the Clinical Translation of Stem Cells: Report of a Focus Session at the ISSCR Tenth Annual Meeting

The authors (from left): Kazuto Kato,^1,2,* Jonathan Kimmelman,³ Jason Robert,⁴ Douglas Sipp,⁵ and Jeremy Sugarman^6,* (see below for their affiliated organizations)

• Related links
• Publication info

12 December 2012

[Cell Stem Cell 11, 765-767; 2012] Alongside the scientific barriers to the clinical translation of stem cell research are ethical and regulatory hurdles. Some of these challenges described by the Ethics and Public Policy Committee, including Professor Kazuto Kato of Osaka University (also of Kyoto University) and Professor Jeremy Sugarman of Johns Hopkins University, at the ISSCR Tenth Annual Meeting are presented in this report. [Read more]

Related links

• ISSCR Ethics and Public Policy Committee

Publication information

Ethical and Policy Issues in the Clinical Translation of Stem Cells: Report of a Focus Session at the ISSCR Tenth Annual Meeting

Kazuto Kato,^1,2,* Jonathan Kimmelman,³ Jason Robert,⁴ Douglas Sipp,⁵ Jeremy Sugarman^6,*

1. Department of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita 565-0871, Japan
2. Institute for Integrated Cell-Material Sciences, Kyoto University, Ushinomiya-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
3. Biomedical Ethics Unit, McGill University, 3647 Peel Street, Montreal, QC H3A1X1, Canada
4. Center for Biology & Society and School of Life Sciences, Arizona State University, PO Box 874701, Tempe, AZ 85287, USA
5. RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan
6. Berman Institute of Bioethics and Department of Medicine, Johns Hopkins University, 1809 Ashland Avenue, Baltimore, MD 21205, USA